Immunic (NASDAQ:IMUX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Immunic (IMUX) operate in?

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.

Open	$1.98
Close	$1.83
Volume / Avg.	929.81K / 374.64K
Day Range	$1.83 - $2.08
52 Wk Range	0.95 - 2.11
Market Cap	$170.25M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	2.62%
Days to Cover	7.06

Recent News

This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

Immunic And 2 Other Stocks Under $2 Insiders Are Buying

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

What's Going On With Immunic Stock?

Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Immunic Inc

Sector

Health Care

Industry

Biotechnology

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral im...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Immunic (IMUX) stock?

You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.

View our list of the best stock brokerages

Who are Immunic (IMUX) competitors?

Other companies in Immunic’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Galectin Therapeutics (NASDAQ:GALT).

What is the forecast, or price target, for Immunic (IMUX) stock?

There is no analysis for Immunic to provide a consensus price target.

What is the current price for Immunic (IMUX)?

The stock price for Immunic (NASDAQ: IMUX) is $1.89 last updated September 20, 2024 at 7:37 PM EDT.

Does Immunic (IMUX) pay a dividend?

There are no upcoming dividends for Immunic.

When is Immunic (NASDAQ:IMUX) reporting earnings?

Immunic’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Immunic (IMUX) going to split?

There is no upcoming split for Immunic.

What sector and industry does Immunic (IMUX) operate in?

Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now